165 related articles for article (PubMed ID: 8615042)
1. Poliovirus recombinants expressing hepatitis B virus antigens elicited a humoral immune response in susceptible mice.
Yim TJ; Tang S; Andino R
Virology; 1996 Apr; 218(1):61-70. PubMed ID: 8615042
[TBL] [Abstract][Full Text] [Related]
2. Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice.
Yue Q; Hu X; Yin W; Xu X; Wei S; Lei Y; Lü X; Yang J; Su M; Xu Z; Hao X
J Virol Methods; 2007 Apr; 141(1):41-8. PubMed ID: 17197041
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
[TBL] [Abstract][Full Text] [Related]
4. [Immunological and virological efficacy against HBV chronic infection of the therapeutic vaccine composed of HBV core plus PreS1 in HBV transgenic mice].
Li MZ; Chen XC; Zhou BP; Le XH; Xu LM; Wang HS
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):277-9. PubMed ID: 15340577
[TBL] [Abstract][Full Text] [Related]
5. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
[TBL] [Abstract][Full Text] [Related]
6. Behavior of a short preS1 epitope on the surface of hepatitis B core particles.
Borisova G; Borschukova O; Skrastina D; Dislers A; Ose V; Pumpens P; Grens E
Biol Chem; 1999 Mar; 380(3):315-24. PubMed ID: 10223334
[TBL] [Abstract][Full Text] [Related]
7. [Immune response in mice induced by the fusion protein of HBcAg and HBV PreS1].
Chen XC; Zhou BP; Li MZ; Wang ZX; Wang HS; Zhang B; Tang W
Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):184-5. PubMed ID: 12681075
[No Abstract] [Full Text] [Related]
8. [Immune response in BALB/c mice immunized with BCG expressing HBV truncated C gene and preS1 gene].
Yin W; Lü X; Lei YF; Yang J; Sun MN; Ma Y; Lan HY; Wang AQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jan; 26(1):28-30. PubMed ID: 20056083
[TBL] [Abstract][Full Text] [Related]
9. Fine mapping of virus-neutralizing epitopes on hepatitis B virus PreS1.
Maeng CY; Ryu CJ; Gripon P; Guguen-Guillouzo C; Hong HJ
Virology; 2000 Apr; 270(1):9-16. PubMed ID: 10772975
[TBL] [Abstract][Full Text] [Related]
10. Hot-spot mutations in hepatitis B virus core gene: eliciting or evading immune clearance?
Liu Z; Luo K; He H; Hou J
J Viral Hepat; 2005 Mar; 12(2):146-53. PubMed ID: 15720529
[TBL] [Abstract][Full Text] [Related]
11. Intracellular single-chain antibody against hepatitis B virus core protein inhibits the replication of hepatitis B virus in cultured cells.
Yamamoto M; Hayashi N; Takehara T; Ueda K; Mita E; Tatsumi T; Sasaki Y; Kasahara A; Hori M
Hepatology; 1999 Jul; 30(1):300-7. PubMed ID: 10385671
[TBL] [Abstract][Full Text] [Related]
12. Multivalent DNA-based immunization against hepatitis B virus with plasmids encoding surface and core antigens.
Musacchio A; Rodriguez EG; Herrera AM; Quintana D; Muzio V
Biochem Biophys Res Commun; 2001 Mar; 282(2):442-6. PubMed ID: 11401479
[TBL] [Abstract][Full Text] [Related]
13. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine.
Li X; Yang X; Li L; Liu H; Liu J
Vaccine; 2006 Apr; 24(16):3321-31. PubMed ID: 16472546
[TBL] [Abstract][Full Text] [Related]
14. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela.
Gutiérrez C; Devesa M; Loureiro CL; León G; Liprandi F; Pujol FH
J Med Virol; 2004 Jun; 73(2):200-7. PubMed ID: 15122793
[TBL] [Abstract][Full Text] [Related]
15. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
[TBL] [Abstract][Full Text] [Related]
16. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
17. Mutated epitopes of hepatitis B surface antigen fused to the core antigen of the virus induce antibodies that react with the native surface antigen.
Shiau AL; Murray K
J Med Virol; 1997 Mar; 51(3):159-66. PubMed ID: 9139078
[TBL] [Abstract][Full Text] [Related]
18. High immunogenicity of a hydrophilic component of the hepatitis B virus preS1 sequence exposed on the surface of three virus-like particle carriers.
Skrastina D; Bulavaite A; Sominskaya I; Kovalevska L; Ose V; Priede D; Pumpens P; Sasnauskas K
Vaccine; 2008 Apr; 26(16):1972-81. PubMed ID: 18343539
[TBL] [Abstract][Full Text] [Related]
19. Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential.
Riedl P; Wieland A; Lamberth K; Buus S; Lemonnier F; Reifenberg K; Reimann J; Schirmbeck R
J Immunol; 2009 Jul; 183(1):370-80. PubMed ID: 19542448
[TBL] [Abstract][Full Text] [Related]
20. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
